MA512902MYOD Monoclonal Antibody 58A and 5 more items

Life Technologies Corporation has been awarded a contract by Virginia Commonwealth University (VCU) with an effective date of June 29, 2026, for the supply of laboratory reagents and biologics. The cumulative contract value totals $2,576.19. The supplies are designated for delivery to VCU Procurement in Virginia. The contract encompasses six distinct line items comprising specialized research materials essential for cellular and molecular biology applications.

The deliverables include monoclonal and polyclonal antibodies (MYOD Monoclonal Antibody 58A, PAX7 Polyclonal Antibody, and Myogenin Monoclonal Antibody F5D), a deoxyribonuclease enzyme (DNase I), and cell culture reagents (Hams F10 Nutrient Mix and Trypsin-EDTA 0.25 percent phenol red). Quantities ordered range from one to three units per line item, with individual unit prices ranging from $25.94 to $619.36. These materials are typical inputs for research conducted in molecular and developmental biology laboratories, supporting investigative work that may involve protein analysis, cell differentiation studies, and cell culture maintenance.